Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Xu, Jie ^a   Sun, Yan ^a   Li, Yize ^b   Ruthel, Gordon ^a   Weiss, Susan R ^b   Raj, Arjun ^c   Beiting, Daniel ^a   López, Carolina B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; CASPASE 3; FRACTALKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 34; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN; STAT5A PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR NFAT4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VISA PROTEIN, HUMAN;

APOPTOSIS; CELLS AND CELL COMPONENTS; GENETIC ANALYSIS; GENOME; IMMUNE RESPONSE; IMMUNITY; INFECTIVITY; PERSISTENCE; SUBPOPULATION; VIRUS;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST; HUMAN; HUMAN CELL; IMMUNITY; NONHUMAN; PARAMYXOVIRIDAE; PERSISTENT INFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SENDAI VIRUS INFECTION; SIGNAL TRANSDUCTION; VIRUS GENOME; CELL LINE; DEFECTIVE VIRUS; GENE KNOCKOUT; GENETICS; METABOLISM; PNEUMOVIRUS; RESPIROVIRUS INFECTION; SENDAI VIRUS; VIROLOGY; VIRUS REPLICATION;

PARAMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS; RNA VIRUSES; SENDAI VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL LINE; CELL SURVIVAL; DEFECTIVE VIRUSES; GENE KNOCKOUT TECHNIQUES; GENOME, VIRAL; HUMANS; PARAMYXOVIRIDAE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 85030768042     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-00909-6     Document Type: Article

References (53)

1. Calain, P., Roux, L. & Kolakofsky, D. Defective interfering genomes and Ebola virus persistence. Lancet 388, 659-660 (2016).
2. Lin, W. H., Kouyos, R. D., Adams, R. J., Grenfell, B. T. & Griffin, D. E. Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc. Natl Acad. Sci. USA 109, 14989-14994 (2012).
3. Sikkel, M. B., Quint, J. K., Mallia, P., Wedzicha, J. A. & Johnston, S. L. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr. Infect. Dis. J. 27, S63-S70 (2008).
4. Ng Cherie, T., Snell Laura, M., Brooks David, G. & Oldstone Michael, B. A. Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe 13, 652-664 (2013).
5. Sun, Y. et al. Immunostimulatory defective viral genomes from respiratory syncytial virus promote a strong innate antiviral response during infection in mice and humans. PLoS Pathog. 11, e1005122 (2015).
6. Lopez, C. B. Defective viral genomes: critical danger signals of viral infections. J. Virol. 88, 8720-8723 (2014).
7. Whistler, T., Bellini, W. J. & Rota, P. A. Generation of defective interfering particles by two vaccine strains of measles virus. Virology 220, 480-484 (1996).
8. Strahle, L., Garcin, D. & Kolakofsky, D. Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 351, 101-111 (2006).
9. Tapia, K. et al. Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog. 9, e1003703 (2013).
10. Yount, J. S., Kraus, T. A., Horvath, C. M., Moran, T. M. & Lopez, C. B. A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J. Immunol. 177, 4503-4513 (2006).
11. Roux, L. & Holland, J. J. Role of defective interfering particles of Sendai virus in persistent infections. Virology 93, 91-103 (1979).
12. Fernandez-Munoz, R. & Celma, M. L. Measles virus from a long-Term persistently infected human T lymphoblastoid cell line, in contrast to the cytocidal parental virus, establishes an immediate persistence in the original cell line. J. Gen. Virol. 73, 2195-2202 (1992).
13. Valdovinos, M. R. & Gomez, B. Establishment of respiratory syncytial virus persistence in cell lines: Association with defective interfering particles. Intervirology 46, 190-198 (2003).
14. Calain, P., Monroe, M. C. & Nichol, S. T. ebola virus defective interfering particles and persistent infection. Virology 262, 114-128 (1999).
15. Huang, A. S. & Baltimore, D. Defective viral particles and viral disease processes. Nature 226, 325-327 (1970).
16. Frensing, T. et al. Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS ONE 8, e72288 (2013).
17. Roux, L., Simon, A. E. & Holland, J. J. Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv. Virus Res. 40, 181-211 (1991).
18. Re, G. G., Gupta, K. C. & Kingsbury, D. W. Genomic and copy-back 3Ê termini in Sendai virus defective interfering RNA species. J. Virol. 45, 659-664 (1983).
19. Leppert, M., Kort, L. & Kolakofsky, D. Further characterization of Sendai virus DI-RNAs: A model for their generation. Cell 12, 539-552 (1977).
20. Kirkwood, T. B. & Bangham, C. R. Cycles, chaos, and evolution in virus cultures: A model of defective interfering particles. Proc. Natl Acad. Sci. USA 91, 8685-8689 (1994).
21. Stauffer Thompson, K. A., Rempala, G. A. & Yin, J. Multiple-hit inhibition of infection by defective interfering particles. J. Gen. Virol. 90, 888-899 (2009).
22. Mercado-Lopez, X. et al. Highly immunostimulatory RNA derived from a Sendai virus defective viral genome. Vaccine 31, 5713-5721 (2013).
23. Bitzer, M. et al. Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J. Virol. 73, 702-708 (1999).
24. Koyama, A. H., Irie, H., Kato, A., Nagai, Y. & Adachi, A. Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins. Microbes Infect. 5, 373-378 (2003).
25. Lee, E. G. et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350-2354 (2000).
26. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. & Baldwin, A. S. Jr NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683 (1998).
27. Liston, P. et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349-353 (1996).
28. Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M. & Goeddel, D. V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243-1252 (1995).
29. Brenner, D., Blaser, H. & Mak, T. W. Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15, 362-374 (2015).
30. Calain, P., Curran, J., Kolakofsky, D. & Roux, L. Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology 191, 62-71 (1992).
31. Chan, Y. K. & Gack, M. U. Viral evasion of intracellular DNA and RNA sensing. Nat. Rev. Microbiol. 14, 360-373 (2016).
32. Herbein, G. & O'Brien, W. A. Tumor necrosis factor (TNF)-Alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 223, 241-257 (2000).
33. Seo, S. H. & Webster, R. G. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J. Virol. 76, 1071-1076 (2002).
34. Aderka, D., Holtmann, H., Toker, L., Hahn, T. & Wallach, D. Tumor necrosis factor induction by Sendai virus. J. Immunol. 136, 2938-2942 (1986).
35. Lorence, R. M., Rood, P. A. & Kelley, K. W. Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-Alpha and augmentation of its cytotoxicity. J. Natl Cancer. Inst. 80, 1305-1312 (1988).
36. Liu, L.-W., Nishikawa, T. & Kaneda, Y. An RNA molecule derived from Sendai virus DI particles induces antitumor immunity and cancer cell-selective apoptosis. Mol. Ther. 24, 135-145 (2016).
37. Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694-699 (2004).
38. Opipari, A. W. Jr., Hu, H. M., Yabkowitz, R. & Dixit, V. M. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267, 12424-12427 (1992).
39. De, A., Dainichi, T., Rathinam, C. V. & Ghosh, S. The deubiquitinase activity of A20 is dispensable for NF-kappaB signaling. EMBO Rep. 15, 775-783 (2014).
40. Greenfeld, H. et al. TRAF1 coordinates polyubiquitin signaling to enhance Epstein-Barr virus LMP1-mediated growth and survival pathway activation. PLoS Pathog. 11, e1004890 (2015).
41. Zhao, M., Zhang, J., Phatnani, H., Scheu, S. & Maniatis, T. Stochastic expression of the interferon-β gene. PLoS Biol. 10, e1001249 (2012).
42. Hu, J. et al. Role of cell-To-cell variability in activating a positive feedback antiviral response in human dendritic cells. PLoS ONE 6, e16614 (2011).
43. Li, Y. et al. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses. Proc. Natl Acad. Sci. USA 113, 2241-2246 (2016).
44. Sun, Y. & López, C. B. Preparation of respiratoryial virus with high or low content of defective viral particles and their purification from viral stocks. Bio-protocol 6(10): e1820 (2016).
45. Xu, J. et al. Identification of a natural viral RNA motif that optimizes sensing of viral RNA by RIG-I. MBio. 6, doi: 10.1128/mBio.01265-15 (2015).
46. Shi, W. A bioconductor R pipeline for analysis of RNA-seq data. Protocol Exchange. http://dx.doi.org/10.1038/protex.2015.039 (2015).
47. Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525-527 (2016).
48. Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: Transcript-level estimates improve gene-level inferences. F1000Research 4, 1521 (2015).
49. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
50. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
51. Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
52. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
53. Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-And-vote. Nucleic Acids Res. 41, e108 (2013).